The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: A single metropolitan Australian center experience

Journal of Crohn's and Colitis

Volumn 4, Issue 4, 2010, Pages 413-421

  van Langenberg, Daniel R ^a   Simon, Stephen B ^a   Holtmann, Gerald J ^a,b,c   Andrews, Jane M ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Care complexity; Healthcare utilization; Inflammatory bowel disease; Inpatient costs; Surgery

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONTROLLED STUDY; COST OF ILLNESS; ENTERITIS; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; COLECTOMY; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HOSPITAL COSTS; HUMANS; INFLAMMATORY BOWEL DISEASES; LENGTH OF STAY; MALE; PATIENT READMISSION; QUALITY OF HEALTH CARE; SOUTH AUSTRALIA;

EID: 77957297936     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2010.01.004     Document Type: Article

References (27)

1. Bewtra M., Su C., Lewis J.D. Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastro Hepatol 2007, 5(5):597-601.
2. Sonnenberg A. Hospitalization for inflammatory bowel disease in the United States between 1970 and 2004. J Clin Gastroenterol 2009, 43(4):297-300.
3. Munkholm P., Langholz E., Davidsen M., Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993, 105:1716-1723.
4. Access economics Pty Ltd. The economic costs of Crohn's disease and ulcerative colitis. Report for Australian Crohn's and Colitis Association, June 2007. Available at http://www.acca.net.au.
5. D'Haens G., Baert F., van Assche G., Caenepeel P., Vergauwe P., et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet Feb 23 2008, 371(9613):660-667.
6. Herrinton L.J., Liu L., Fireman B., Lewis J.D., Allison J.E., Flowers N., et al. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology 2009, 137:502-511.
7. Carter M.J., Lobo A.J., Travis S.P.L. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004, 53(Suppl V):v1-v16. on behalf of BSG-IBD group.
8. Longobardi T., Bernstein C.N. Health care resource utilization in inflammatory bowel disease. Clin Gastro Hepatol 2006, 4:731-743.
9. Bodger K. Cost of illness of Crohn's disease. Pharmacoeconomics 2002, 20(10):639-652.
10. CNAHS website. Accessed Jan 2009. Available at http://www.health.sa.gov.au/cnahs/.
11. Stjernman H., Tysk C., Almer S., Strom M., Hjortswang H. Factors predicting the outcome of disease activity assessment in Crohn's disease. Inflamm Bowel Dis July 2 2009, 15(12):1859-1866.
12. Sostegni R., Daperno M., Scaglione N., Lavagna A., Rocca R., Pera A. Review article: Crohn's disease: monitoring disease activity. Aliment Pharmacol Ther 2003, 17(Suppl. 2):11-17.
13. Harvey R.F., Bradshaw J.M. A simple index of Crohn's disease activity. Lancet 1980, 1(8167):514.
14. de Jonge P., Huyse F.J., Stiefel J.C. Case and care complexity in the medically ill. Med Clin North Am 2006, 90(4):679-692.
15. Butler J.R.G. Hospital cost analysis 1995, 306-307. Kluwer Academic Publishers, Chapter 10.
16. Australian Institute of Health of Welfare (Federal Government of Australia). Australian Hospital Statistics 2005-06 May 2007, 263. Chapter 12.
17. Titulaer I, Hargreaves J. Constructing a relative stay index for national hospital data comparison..Proceedings of Health Care in Focus 1-4 September 2002, Commonwealth Department of Health and Ageing, Canberra 2002.
18. Hornbrook M.C. Techniques for assessing hospital case mix. Ann Rev Public Health 1985, 6:295-324.
19. Feagan B.G., Yan S., Bala M., Bao W., Lichtenstein G.R. The effects of infliximab maintenance therapy on health-related quality of life. Am J Gastroenterol Oct 2003, 98(10):2232-2238.
20. Lichtenstein G.R., Yan S., Bala M., Hanauer S. Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol Jan 2004, 99(1):91-96.
21. Longobardi T., Jacobs P., Bernstein C.N. Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis. Am J Gastro 2004, 99:650-655.
22. van der Eijk I., Vlachonikolos I.G., Munkholm P., Nijman J., Bernklev T., Politi P., et al. The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis 2004, 392-398.
23. Nabalamba A., Bernstein C.N., Seko C. Inflammatory bowel disease-hospitalization. Health Rep 2004, 15(4):25-40.
24. Mussell M., Bocker U., Nagel N., Singer M.V. Predictors of disease related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastro Hepatol 2004, 16:1273-1280.
25. Casellas F., Lopez-Vivancos J., Badia X., Vilaseca J., Malegelada J.R. Impact of surgery for Crohn's disease on health related quality of life. Am J Gastroenterol 2000, 95(1):177-182.
26. Thirlby R.C., Sobrino M.A., Randall J.B. The long term benefit of surgery on health related quality of life in patients with inflammatory bowel disease. Arch Surg 2001, 136:521-527.
27. Gibson P.R., Weston A.R., Florin T.H.J., Lawrance I.C., Macrae F.A., Radford-Smith G. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease. J Gastro Hepatol 2007, 22:1306-1312.